Recurrent Syncope: Initial Presentation of Transthyretin Amyloidosis. Benefits of Disease-Modifying Treatment
ABC: Heart Failure & Cardiomyopathy · 2021
DOI: 10.36660/abchf.20210014 ↗Kurz gefasst
Fachartikel in der Zeitschrift ABC: Heart Failure & Cardiomyopathy, 2021. Verfasst von Edileide de Barros Correia und 6 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Correia, E. D. B., Bruscky, L. V. R., Valério, B. C. O., Murta, A. C. D. S., Albrecht, F. C., Pinto, I. M. F., & Smanio, P. E. P. (2021). Recurrent Syncope: Initial Presentation of Transthyretin Amyloidosis. Benefits of Disease-Modifying Treatment. ABC: Heart Failure & Cardiomyopathy. https://doi.org/10.36660/abchf.20210014
Vancouver
Correia EDB, Bruscky LVR, Valério BCO, Murta ACDS, Albrecht FC, Pinto IMF, et al. Recurrent Syncope: Initial Presentation of Transthyretin Amyloidosis. Benefits of Disease-Modifying Treatment. ABC: Heart Failure & Cardiomyopathy. 2021. doi:10.36660/abchf.20210014
BibTeX
@article{Correia2021,
author = {Correia, Edileide de Barros and Bruscky, Larissa Ventura Ribeiro and Valério, Berenice Cataldo Oliveira and Murta, Ana Cristina de Souza and Albrecht, Fabiano Castro and Pinto, Ibraim Masciarelli Francisco and Smanio, Paola Emanuela Poggio},
title = {Recurrent Syncope: Initial Presentation of Transthyretin Amyloidosis. Benefits of Disease-Modifying Treatment},
journal = {ABC: Heart Failure & Cardiomyopathy},
year = {2021},
doi = {10.36660/abchf.20210014}
}
EUVIMED